Variant report
Variant | esv2762607 |
---|---|
Chromosome Location | chr6:93180428-93214365 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532452426 | chr6:93182223-93182224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2730850 | chr6:93182233-93182234 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs559305297 | chr6:93182245-93182246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571429041 | chr6:93182263-93182264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536913061 | chr6:93182290-93182291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs567791101 | chr6:93182294-93182295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144711953 | chr6:93182295-93182296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577420125 | chr6:93182315-93182316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550872589 | chr6:93182338-93182339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570915338 | chr6:93182349-93182350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540128362 | chr6:93182369-93182370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553385957 | chr6:93182397-93182398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs186935545 | chr6:93182409-93182410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147916232 | chr6:93182419-93182420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555926389 | chr6:93182459-93182460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368237812 | chr6:93182480-93182481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575830062 | chr6:93182482-93182483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544685760 | chr6:93182516-93182517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141520668 | chr6:93182522-93182523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191822066 | chr6:93182536-93182537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs9452023 | chr6:93182537-93182538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546126813 | chr6:93182551-93182552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563893920 | chr6:93182620-93182621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371374249 | chr6:93182702-93182703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1896234 | chr6:93182761-93182762 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs181209941 | chr6:93182811-93182812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561310833 | chr6:93182875-93182876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs199684913 | chr6:93182939-93182940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200997139 | chr6:93182958-93182959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574965517 | chr6:93182974-93182975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1427143 | chr6:93183034-93183035 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs550213201 | chr6:93183051-93183052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185304310 | chr6:93183138-93183139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549623663 | chr6:93183149-93183150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145380131 | chr6:93183246-93183247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560209057 | chr6:93183254-93183255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1427142 | chr6:93183255-93183256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577826690 | chr6:93183316-93183317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200488269 | chr6:93183317-93183318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555816321 | chr6:93183319-93183320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569237953 | chr6:93183324-93183325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113060107 | chr6:93183372-93183373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538348486 | chr6:93183378-93183379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528450850 | chr6:93183402-93183403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557969903 | chr6:93183467-93183468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76719198 | chr6:93183490-93183491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76238998 | chr6:93183498-93183499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553102176 | chr6:93183511-93183512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189762224 | chr6:93183534-93183535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs541681274 | chr6:93183573-93183574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuropathy | 19664229 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:93182200-93182600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr6:93182200-93182800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr6:93182400-93182800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:93182400-93182800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr6:93182400-93182800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr6:93182800-93183600 | Enhancers | HUVEC | blood vessel |
7 | chr6:93189400-93190200 | Enhancers | HUVEC | blood vessel |
8 | chr6:93189600-93190000 | Enhancers | Fetal Heart | heart |
9 | chr6:93190000-93191400 | Weak transcription | Fetal Heart | heart |
10 | chr6:93191400-93192000 | Enhancers | Fetal Heart | heart |
11 | chr6:93192000-93198000 | Weak transcription | Fetal Heart | heart |
12 | chr6:93198000-93199000 | Enhancers | Fetal Heart | heart |
13 | chr6:93204200-93205000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
14 | chr6:93204400-93205200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr6:93205000-93205200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr6:93205000-93206000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
17 | chr6:93205200-93206200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr6:93205200-93206200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr6:93206200-93206400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
20 | chr6:93206200-93206600 | Enhancers | H1 Cell Line | embryonic stem cell |
21 | chr6:93206200-93206600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
22 | chr6:93206200-93206600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
23 | chr6:93206200-93206600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
24 | chr6:93206200-93206600 | Enhancers | Ovary | ovary |
25 | chr6:93206200-93206800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
26 | chr6:93206800-93207800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
27 | chr6:93207800-93208200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |